The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of selective ATP-competitive eIF4A3 inhibitors.EBI
Takeda Pharmaceutical
Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1EBI
Takeda Pharmaceutical
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.EBI
Takeda Pharmaceutical
Discovery of spiro[indole-3,2'-pyrrolidin]-2(1H)-one based inhibitors targeting Brr2, a core component of the U5 snRNP.EBI
Takeda Pharmaceutical
Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.EBI
Takeda California
Thermodynamic consequences of grafting enhanced affinity toward the mutated antigen onto an antibody. The case of anti-lysozyme antibody, HyHEL-10.BDB
Tohoku University